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Introduction 
 
One of the important steps of inflammation is 
polymorphonuclear leukocyte (PMN) recruit-
ment from the bloodstream to inflammatory 
sites through interactions with postcapillary 
venule endothelial cells [1]. The mechanism of 
cellular migration is triggered by a series of pro-
inflammatory mediators that are produced by 
mast cells, macrophages, activated endothelial 
cells, and leukocytes that have transmigrated to 
the inflamed tissue [2]. In addition, the inflam-
matory response is controlled by the action of 
anti-inflammatory mediators, which act to main-
tain homeostasis of the immune response and 
prevent tissue damage. Among these media-
tors, highlight the galectin-1 (Gal-1), a 14.5-kDa 
protein which acts as an endogenous modulator 
of inflammation [3]. 
Gal-1 belongs to a family of proteins involved in 
inflammatory processes, characterized by an 
affinity for galactosides-β and a conserved 
sequence of 130 amino acids in the 
carbohydrate recognition domain (CRD) [4, 5]. 
The expression of Gal-1 was observed in various 
cell types associated with the inflammatory 
response, especially neutrophils and mast cells 
[3, 6], macrophages [7], T and B lymphocytes 
[8, 9], and endothelial cells [3, 6, 10], 
suggesting an important role in the generation 
and maintenance of immune tolerance. 
 
In acute inflammation, the anti-inflammatory 
action of Gal-1 was observed in an experimental 
model of paw edema in rats [11]. Exogenous 
administration of this protein, 30 minutes be-
fore or together with phospholipase A2 from bee 
venom, was able to inhibit PMN extravasation, 
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analysis of PMNs showed significant Gal-1 expression and co-localization with L-selectin and β2-integrin in the 
plasma membrane and cytoplasm.  Pharmacological treatment with hrGal-1 at 4 h produced an inhibition of PMN 
migration, associated with diminished expression of adhesion molecules, particularly β2-integrin, and TNF-α and IL-
1β release by peritoneal cells. At 24 h, Gal-1 induced an increase in mononuclear phagocytic cell recruitment. In con-
clusion, our data propose an important mechanism of anti-inflammatory action of Gal-1, initially by modulation of pro-
inflammatory cytokine release and PMN migration through an imbalance between adhesion molecule expression 
and, later, by promoting monocyte-macrophage recruitment.  
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mast cell degranulation, and arachidonic acid 
and prostaglandin E2 release by lipopolysaccha-
ride (LPS)-stimulated macrophages. 
 
The anti-inflammatory role of Gal-1 in PMN re-
cruitment was also shown in in vitro and in vivo 
experimental models [3, 6, 10, 12]. Incubation 
of human PMN with human recombinant (hr) 
Gal-1 significantly decreased the extent of cap-
ture, rolling, and adhesion on activated endo-
thelial monolayers [10, 12]. Furthermore, Gal-1 
inhibited the platelet-activating factor-induced 
increase in β2-integrin expression in PMNs in a 
concentration-dependent manner, as assessed 
by flow cytometry [12]. Investigations using in 
vivo models showed that pre-administration of 
Gal-1 promoted an inhibition of PMN extravasa-
tion to the peritoneal cavity after 4 hours of car-
rageenan application in rats [3] and IL-1β in 
mice [10]. Similarly, the exogenous Gal-1 re-
duced the capture process of PMNs by endothe-
lial cells in mesenteric circulation [10], and the 
lack of endogenous Gal-1 caused a significant 
increase in PMN adhesion and emigration in 
cremasteric circulation in Gal-1-null mice [12]. 
These studies suggest a role of this protein in 
the modulation of adhesion molecules associ-
ated with interaction of PMNs and the endothe-
lium, particularly L-selectin and β2-integrin. 
 
Given the anti-inflammatory role of Gal-1, the 
purpose of this study was to investigate the ef-
fect of pharmacological pretreatment with hrGal
-1 in experimental peritonitis induced by zymo-
san in mice, focusing on the recruitment of in-
flammatory cells, release of proinflammatory 
cytokines, and modulation of L-selectin and β2-
integrin adhesion molecules. The co-locatization 
of Gal-1 and adhesion molecules during PMN 
interaction with endothelial cells was assessed 
by ultrastructural immunocytochemical studies. 
 
Materials and methods 
 
Animals 
 
Male C57BL/6 mice (20–25 g of body weight), 
maintained on a standard chow pellet diet with 
tap water ad libitum, were used for all experi-
ments. Animals were housed at a density of 6 
animals per cage in a room with controlled light-
ing (lights on from 8:00 a.m. to 8:00 p.m.), in 
which the temperature was maintained at 21–
23°C. Animal work was performed according to 
the Committee on Care and Use of Laboratory 
Animal Resources of the School of Medicine 
(Protocol nº 3015/06), São Jose do Rio Preto, 
SP. 
 
Zymosan peritonitis 
 
Experimental peritonitis was induced by i.p. in-
jection of 1 mg of boiled zymosan A (Sigma-
Aldrich) in 0.5 ml of sterile saline [13], whereas 
control animals were injected with an equal vol-
ume of saline. At different time points (0, 4, and 
24 hours), animals (n=6 per group) were anes-
thetized with ketamine and xylazine (100 and 
20 mg/Kg, i.p.) for collection of blood aliquots 
(maximum 1 ml) before sacrifice and washing of 
the peritoneal cavity with 3 ml of PBS supple-
mented with 3 mM EDTA. Then, fragments of 
the mesentery were collected and processed as 
described below.  
 
In another set of experiments, mice were 
treated with an i.p. injection of 0.3 µg of hrGal-1 
(Peprotech, EC Ltd, London, UK) in 100 µl of 
sterile saline 15 minutes before the zymosan 
injection. This dose was scaled up from a 
previous study of an inflammation model in 
mouse [10]. PMN recruitment into the 
peritoneal cavity, blood, and mesentery was 
assessed at the 4- and 24-h time-points.  
 
Cellular analyses 
 
Cell Quantification. Aliquots of blood (20 µl) or 
peritoneal lavage fluid (100 µl) were diluted 
1/10 in Turk’s solution (0.1% crystal violet in 
3% acetic acid); total and differential counting 
was obtained with a Neubauer chamber using a 
40x objective and a light microscope (Zeiss). 
Peritoneal cells and blood were distinguished in 
PMNs and monocytes/macrophages (mono-M
). Data were reported as mean  SEM of the 
average number of cells x 105 / mL from blood 
samples and the number of cells x 105 per 
animal from the peritoneal exudate. 
 
Blood Flow Cytometry.  In order to quantify L-
selectin (CD62L) or β2-integrin (CD11b) expres-
sion, leukocytes were isolated from abdominal 
aorta blood collected in EDTA (100 mg/mL). 
Erythrocyte lysis was performed using an ammo-
nium chloride solution (0.13 M), and leukocytes 
were recovered after washing the preparation 
with PBS. The cells (1.0 x 106) were incubated 
for 30 min at 4ºC in the dark with 10 µL of 
monoclonal antibodies against L-selectin conju-
gated to PE (anti-mouse CD62L) and β2-integrin 
conjugated to FITC (anti-mouse CD11b) (BD 
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Pharmigen, San Diego, USA). Immediately after 
incubation, the cells were analyzed using a FAC-
SCalibur flow cytometer (Becton & Dickinson, 
San Jose, CA, USA). Data were obtained from 
10,000 cells and only morphologically viable 
neutrophils were considered for analysis. Leuko-
cytes were separated based on size and granu-
larity. Fluorescence was determined and the 
results are expressed as the mean fluorescence 
of two assays performed in duplicate. 
 
Biochemical analysis  
 
Cytokine levels. Aliquots of peritoneal lavage 
fluid were centrifuged at 400 x g for 10 min and 
tested for TNF-α, IL-1β, and IL-6 according to 
the manufacturer’s protocol (R&D Systems).  
 
Histological analysis 
 
Mesentery flat mount. Fragments of mesentery 
were stretched with pins and fixed in formalin 
10% for 30 minutes. After, they were washed 
with distilled water, stained by toluidine blue 
solution (30 min), separated from the small 
intestine and distended on the slides for histo-
logical quantification of the inflammatory cells. 
Analysis of cells in the mesenteric connective 
tissue was performed at 0, 4, and 24 hours post
-zymosan administration with or without prior 
drug treatment (hrGal-1) with a high-power ob-
jective (40x), counting mast cells and PMNs in 1 
mm2 area (analyzing at least 10 sections of tis-
sues per group). Values are reported as mean ± 
SEM of the number of cells per mm2.   
 
Ultrastructural immunocytochemical analysis   
 
Blood aliquots and mesentery fragments at 4h 
post-zymosan administration were fixed in 4% 
paraformaldehyde and 0.5% glutaraldehyde, 
0.1% sodium cacodylate buffer (pH 7.4) for 24 h 
at 4°C. They were then washed in sodium caco-
dylate, dehydrated through a graded series of 
methanol, and embedded in LR Gold (London 
Resin Co., Reading, Berkshire, UK). Sections 
(0.5 µm) were stained with 1% toluidine blue in 
1% Borax solution (TAAB Laboratories, Alder-
maston, Berkshire, UK). Sections (70 nm) were 
cut on an ultramicrotome (Reichert Ultracut; 
Leica, Austria) and placed on nickel grids for 
immunogold labeling. 
 
To detect the expression of Gal-1 and adhesion 
molecules (CD11b and CD62L) on PMNs of 
blood and mesenteries (intravascular and trans-
migrated cells), a post-embedding immunogold 
double labeling reaction was performed. Ultra-
thin sections were incubated with: (1) phos-
phate-buffered solution (PBS) containing 1% 
egg albumin (PBEA); (2) PBS containing 5% egg 
albumin (PBEA) for 30 min; (3) polyclonal rabbit 
anti-Gal-1 (1:100) (Peprotech, London, UK) and 
polyclonal goat anti-CD11b (1:200) or mono-
clonal rat anti-CD62L (1:50) (Santa Cruz Bio-
technology, California, USA) for 2 h; (4) normal 
rabbit serum and normal goat or rat serum, re-
spectively, were used as control; (5) after 
washes in PBEA, in order to detect Gal-1, goat 
anti-rabbit IgG antibody (1:100 in PBEA) conju-
gated to 15 nm colloidal gold (British Biocell, 
Cardiff, UK) was added, and to detect CD11b or 
CD62L, rabbit anti-goat or goat anti-rat IgG anti-
body (1:100 in PBEA) conjugated to 10 nm col-
loidal gold (British Biocell) was added; and (6) 
after 1 h, the sections were washed in PBEA 
and then in distilled water.  
 
Ultrathin sections were stained with uranyl ace-
tate and lead citrate before examination on a 
ZEISS LEO 906 electron microscope (Electron 
Microscope Centre, IBILCE-UNESP). Randomly 
photographed sections of intravascular and 
transmigrated PMN to the tissue were used for 
the immunocytochemical analysis. The area of 
the cell compartment was determined with Axio-
vision software. The density of immunogold 
(number of gold particles per µm2) was calcu-
lated and expressed for each cell compartment. 
Values are reported as mean ± SEM of n elec-
tron micrographs analyzed.  
 
Statistical analysis 
 
Statistical differences between means were 
determined by one-way analysis of variance 
(ANOVA), followed, if significant, by Bonferroni 
test. When 2 variables were analyzed, Student’s 
t-test was used. A probability value less than 
0.05 was taken as significant.  
 
Results 
 
Effect of exogenous Gal-1 on migration of in-
flammatory cells 
 
Initially, we analyzed the effect of i.p. admini-
stration of zymosan in mice at different times 
(0, 4, and 24 hours). After 4 h of peritonitis in-
duction, an intense inflammatory response was 
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characterized by an increase in the number of 
PMNs in blood (16 ± 3 x 105 cells/ml) and peri-
toneal exudate (89 ± 18 x 105 cells/animal), 
compared with the control group (8 ± 3 x 105 
cells/ml and 3 ± 2 x 105 cells/animal, respec-
tively). In the latter experimental time, 24 h, the 
levels of PMN decreased in the blood (5 ± 1 x 
105 cells/ml) and peritoneal wash (7 ± 2 x 105 
cells / animal), as observed in the control 
group.  
 
Mononuclear phagocytic cells (mono-M) 
increased significantly at 4 h in the peritoneal 
wash (51 ± 6 x 105 cells/animal) compared to 
the control group (14 ± 5 x 105 cells/animal), 
followed by a decrease after 24 hours (28 ± 9 x 
105 cells/animal). In the blood, no significant 
change was demonstrated in the number of 
monocytes at differential times.  
  
The effect of pharmacological pretreatment with 
human recombinant (hr) Gal-1 on the migration 
of inflammatory cells was evaluated in this 
model of zymosan peritonitis. After 4 h, a signifi-
cant decrease in the number of blood and peri-
toneal PMNs was demonstrated in the pre-
treated group compared to untreated animals 
(Figure 1A and C). No effect of exogenous Gal-1 
was noted on PMNs at 24 h (Figure 1A and C). 
Similarly, the quantification of monocytes re-
vealed no significant differences in the blood 
samples of animals pretreated or not with hrGal
-1 in the experimentally investigated times 
(Figure 1B). However, the peritoneal exudate of 
pretreated animals showed a significant in-
crease of these cells compared to the untreated 
group after 24 h (Figure 1D). 
 
Besides alteration in blood cell counts, PMN of 
mice pretreated with hrGal-1 displayed a signifi-
cantly higher degree of activation at 4h, as as-
sessed by CD62L expression (Figure 2A and C). 
At 24h, the effect of pharmacological treatment 
was associated with high significant levels of 
CD11b on PMN compared to cells of untreated 
mice (Figure 2B and D). 
 
Cytokine detection  
 
Similar to cell trafficking, the profiles of cytokine 
levels were markedly altered by pharmacologi-
cal treatment with hrGal-1 at 4 h. Table 1 illus-
trates the values obtained for the cytokine con-
tent from peritoneal lavage fluid. In untreated 
mice, zymosan provoked the expected transient 
increase in TNF-α, followed by changes in inter-
leukin (IL)-1β and IL-6. In mice pretreated with 
hrGal-1, the TNF-α and IL-1β response was di-
minished significantly at this time point. In the 
presence of exogenous hrGal-1, the IL-6 re-
sponse was not changed. At 24h, cytokine levels 
were not detected in any experimental group.  
Figure 1. Effect of hrGal-1 on 
leukocyte migration during 
acute peritonitis model. Density 
of neutrophils (PMNs) and 
mononuclear phagocytic cells 
(mono-M) from blood (A-B) and 
peritoneal wash (C-D) after 4h 
and 24h of zymosan admini-
stration in mice pretreated in-
traperitoneally with vehicle 
(PBS) or hrGal-1 (0.3 µg). Data 
are mean ± SEM from two 
separate experiments with 4 
mice each. * P < 0.05 versus 
corresponding vehicle group 
value.  
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Histological studies 
Similar to cytokine release and cell trafficking, 
the profiles of the histological analysis were 
markedly altered on pharmacological treatment 
with hrGal-1. Morphological analysis of the mes-
entery of mice, 4 h post-zymosan, showed in-
tense migration of PMNs (44 ± 10 cells/mm2) 
from postcapillary venules to the connective 
tissue compared to control animals (1 ± 0.5 
Figure 2. L-selectin and β2-integrin expressions on circulating leukocytes. Mice pretreated intraperitoneally with vehi-
cle (PBS) or hrGal-1 (0.3 µg) received 1mg of zymosan i.p. at time 0. At different time points after zymosan, blood was 
collected and L-selectin (A) and β2-integrin (B) expressions on leukocytes quantified by flow cytometry. Representa-
tive flow histograms of L-selectin (C) and β2-integrin (D) after 4 and 24h respectively showing differences between 
vehicle and hrGal-1 treated groups. Data are mean ± SEM from two experiments performed with three mice each. *P 
< 0.05 versus correspondent vehicle group value. 
 
Table 1. Effect of hrGal-1 on soluble mediators release 
Group / Treatment TNF-α (pg/ml) IL-1β (pg/ml) IL-6 (pg/ml) 
Control ND ND ND 
4h / vehicle 91.93 ± 13.5 374.4 ± 44.38 668 ± 46.94 
4h/ hrGal-1 30.07 ± 10.93* 139.8 ± 35.57* 724.6 ± 20.13 
24h / vehicle ND ND ND 
24h / hrGal-1 ND ND ND 
Mice pretreated intraperitoneally with vehicle (PBS) or hrGal-1 (0.3 µg) received 1mg of zymosan i.p. at time 0. Lav-
age fluid was collected at 0, 4 and 24h later, and serum concentrations of TNF-α, IL-1β, and IL-6 were determined. 
Results are from 6 mice per group. ND, not detected. *P < 0.05 versus corresponding vehicle group values. 
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cells/mm2). At this time, pharmacological treat-
ment with hrGal-1 caused a reduction in the 
number of transmigrated PMN (2 ± 1 cells/
mm2) in relation to untreated animals. Although 
a high mast cell density (14 ± 2 cells/mm2) and 
activation (7 ± 1 degranulated cells/mm2) were 
noted in the 4-h-inflamed mesentery compared 
to control (5 ± 2 cells/mm2; 3 ± 1 degranulated 
cells/mm2), no significant effect of administra-
tion of hrGal-1 was detected in these cells (11 ± 
2 cells/mm2; 9 ± 2 degranulated cells/mm2). 
 
After 24 h, a significant reduction in PMN infil-
tration and mast cell number (55%) was ob-
served in the mesentery of untreated animals. 
Treatment with hrGal-1 did not produce differ-
ent changes in the response of PMNs (4 ± 2 
cells/mm2) or mast cells (9 ± 2 cells/mm2) com-
pared to untreated animals at 24 h (4 ± 2 PMN/
mm2; 5 ± 1 mast cells/mm2).  
 
Immunogold analysis of Gal-1 and adhesion 
molecules in the neutrophils 
 
The expression of Gal-1 and the adhesion mole-
cules L-selectin (CD62L) and β2-integrin 
(CD11b) was detected by postembedding immu-
nogold labeling and analyzed to define their sub-
Figure 3. Analysis of Gal-1 and adhesion molecule (L-selectin and β2-integrin) co-localization in peripheral blood neu-
trophils. At 4 h of zymosan administration, several points of co-localization of Gal-1 (arrows; 15 nm colloidal gold) and 
β2-integrin and L-selectin (A and D, respectively; arrowheads; 10 nm colloidal gold) were localized in the plasma 
membrane and cytoplasm of neutrophils. Pretreatment with hrGal-1 induced diminished β2-integrin (B) and L-selectin 
(E) expression. Density of β2-integrin (C) and L-selectin (F) immunogold particles in blood neutrophils at 4h post-
zymosan administration in mice pretreated or not (vehicle) with hrGal-1. Data are mean ± SEM of 10 distinct cells for 
each group analyzed in the peripheral blood samples of 4 mice. *P < 0.001 versus correspondent vehicle group 
value. 
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cellular co-localization in the neutrophils of 
blood and those that were undergoing recruit-
ment at 4 h in mesentery. 
 
In this acute phase of inflammation, blood neu-
trophils of untreated animals presented co-
localization between Gal-1 and adhesion mole-
cules (CD62L and CD11b) that was detected 
throughout the cytosol, with a significant propor-
tion also being observed in the plasma mem-
brane (Figure 3A and D). Pretreatment of mice 
with hrGal-1 greatly diminished the CD11b 
(Figure 3B) and CD62L expression (Figure 3E), 
confirmed by the density of immunogold parti-
cles associated with them (Figure 3C and F).  
 
Similarly, mesenteric neutrophils (intravascular 
and transmigrated) of untreated animals 
showed points of co-localization between Gal-1 
and CD11b expression in the plasma mem-
brane and cytosol (Figure 4A), which was poorly 
observed for CD62L (Figure 4B). The exogenous 
administration of hrGal-1 produced in the neu-
trophils a significant decrease of CD11b immu-
noreactivity in their subcellular compartments 
(plasma membrane and cytosol) (Figure 4C), 
while CD62L expression was greatly increased 
in these cells (Figure 4D). No immunogold label-
ing was detected in sections incubated with con-
trol nonimmune sera (Figure 4E). The ultrastruc-
tural observations were confirmed by quantifica-
tion of gold particles associated with adhesion 
molecules, shown in Figure 4, F and G.  
 
Discussion 
 
In spite of significant advances in elucidating 
the role of galectin-1 (Gal-1) within models of 
autoimmune conditions, focusing on T- and B-
cells [14-16], the effects of this protein toward 
the cells of innate immunity have not been stud-
ied in such detail. We began the present study 
by validating this effect using a classical model 
of acute inflammation induced by zymosan in 
mice [17, 18]. Furthermore, the pharmacologi-
cal treatment with human recombinant (hr) Gal-
1 was investigated in innate immune cell re-
cruitment, particularly polymorphonuclear leu-
kocytes (PMNs) and mononuclear phagocytic 
cells, and in the expression of the adhesion 
molecules β2-integrin (CD11b) and L-selectin 
(CD62L) during the process of PMN 
transmigration in the mouse mesentery. 
  
Administration of exogenous hrGal-1 before 
induction of zymosan peritonitis produced an 
inhibition of PMN recruitment to the peritoneal 
cavity (~70%), blood (50%), and mesentery 
(~80%), after 4 h, the peak of the inflammatory 
process. This anti-migratory effect of the protein 
was associated with inhibition of the release of 
the proinflammatory cytokines TNF-α and IL-1β 
but not IL-6. Similar results were described in 
vitro assays for Gal-1 that abrogated the pro-
duction of the pro-inflammatory cytokines TNF-α 
and interferon (IFN)-g by activated macrophages 
and T cells and in plasma from mice with conca-
navalin A-induced hepatitis [19, 20]. On the 
other hand, the Gal-1 anti-migratory effect in 
peritonitis induced by IL-1β in wild-type and 
knockout mice [10, 12], was not associated 
with chemokine KC (CXCL1) or prostaglandin E2 
(PGE2) reduction [10]. These data indicate that 
Gal-1 regulates the acute phase of the 
inflammatory response by controlling specific 
proinflammatory cytokine release, particularly 
those associated with macrophage activation.   
 
Mesentery inflammation induced by zymosan 
was characterized by a significant proportion of 
mast cell degranulation (~70%) at 4 h, along 
extensive PMN infiltration, followed by a de-
crease at 24 h (~30%). The importance of mast 
cells in PMN migration in this peritonitis model 
was demonstrated by selective depletion of 
these cells, which provoked a lower influx of 
PMNs to the peritoneal cavity [18], as well as in 
the arthritis model in mice treated with a mast 
cell stabilizer, nedocromil [21]. Although our 
results showed diminished PMN migration asso-
ciated with hrGal-1 pharmacological treatment, 
no differences were seen in the number or pat-
tern of mast cell degranulation compared to the 
untreated group. On the other hand, a study 
using PLA2-induced paw edema in rats de-
scribed a diminished number of degranulated 
mast cells associated with exogenous Gal-1 
administration at different doses, but no effect 
was noted in histamine-induced edema, show-
ing a selective role of Gal-1 for PLA2 at the level 
of arachidonic acid release, particularly by 
macrophages [11]. In this sense, our findings 
suggest that the anti-inflammatory role of Gal-1 
in the recruitment of PMNs in the initial phase 
of inflammation occurs through a mechanism 
independent of mast cell modulation. 
 
In light of our previous studies in which endoge-
nous Gal-1 in mononuclear phagocytic cells 
could be modulated under different inflamma-
Exogenous galectin-1 on leukocyte migration 
 
 
81                                                                                                              Int J Clin Exp Pathol 2011;4(1):74-84 
tory stimuli [3], we also addressed the exoge-
nous administration of Gal-1 to these cells. The 
main changes provoked by pretreatment with 
hrGal-1 in mononuclear phagocytic cells were 
Figure 4. Expression of Gal-1 and adhesion molecule (β2-integrin and L-selectin) in transmigrated neutrophils (Ns) of 
mesenteric tissue. Ns showed a significant proportion of Gal-1 (arrows; 15 nm colloidal gold) and β2-integrin 
(arrowheads; 10 nm colloidal gold) co-localization in the plasma membrane and cytoplasm (A) that was poorly ob-
served for L-selectin (B; arrowheads; 10 nm colloidal gold) at 4h of peritonitis. Nucleus (N). Pretreatment with hrGal-1 
induced diminished β2-integrin (C) and augmented L-selectin expression (D). (E) Absence of gold labeling in control 
section of reaction. Scale bars, 0.5µm. Density of β2-integrin (F) and L-selectin (G) immunogold particles in intravas-
cular (Nin) and transmigrated Ns (Nout) at 4 h post-zymosan administration in mice pretreated or not with hrGal-1. 
Data are mean ± SEM of 10 distinct cells for each group analyzed in the mesenteric tissue samples of 4 mice. *P < 
0.01 versus correspondent Nin and Nout values. 
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observed in mouse peritoneal exudate at 24 h, 
with a significant increase in the number of 
these cells compared to the untreated group, 
revealing a role of this protein in monocyte 
chemotaxis. This chemotactic effect of Gal-1 is 
associated with its carbohydrate binding func-
tion (reduced by 65% in the presence of lac-
tose) and the MAP kinase pathways, as demon-
strated by in vitro assays [22]. Additionally, ad-
ministration of exogenous Gal-1 appears to play 
a role in the activation of these cells, particu-
larly dendritic cells, increasing the secretion of 
proinflammatory cytokines [23].  
 
The effect of CD11b and CD62L expression in 
PMNs from animals treated (or not) with hrGal-1 
was tested in this study. In early acute inflam-
mation, blood and mesenteric neutrophils of 
untreated animals presented a significant pro-
portion of co-localization between Gal-1 and 
adhesion molecules (CD11b and CD62L) in the 
plasma membrane and cytosol, observed par-
ticularly in the blood cells. In fact, integrins act 
as ligands of Gal-1 protein for cell adhesion to 
extracellular matrix, as demonstrated by mo-
lecular investigations carried out with macro-
phages [24] and muscle cells [25-27]. Our data 
indicate that pharmacological treatment with 
hrGal-1 greatly augmented expression of the 
CD62L on blood PMN plasma membranes, as 
detected by flow citometry, while endogenous 
CD62L and CD11b levels were significantly di-
minished in these cells compared to untreated 
animals, showing an important mechanism of 
this protein to inhibit cell migration. Curiously, 
once in contact with the mesentery, PMNs con-
tinue to express low levels of CD11b associated 
with hrGal-1 administration, but, in contrast, 
CD62L levels augment significantly. This latter 
effect could explain the high number of PMNs at 
24 h in the hrGal-1-treated animals compared 
to the vehicle group. However, no Gal-1 effect 
was found on CD62L expression in the studies 
conducted by Cooper et al. [12], which demon-
strated an inhibitory role of hrGal-1 administra-
tion in the steps of rolling and firm adhesion of 
platelet-activating factor (PAF)-stimulated PMNs 
to endothelial cells by significantly decreasing 
CD11b expression. The data showed clearly that 
exogenous Gal-1 downregulates CD11b expres-
sion, but its effect on CD62L warrants further 
investigation. 
 
Several studies have demonstrated the impor-
tance of the CD11b and CD62L adhesion mole-
cules in the transmigration of PMNs at sites of 
injury, representing critical points of the im-
mune response of host defense [28-30]. Con-
current with the increased levels of CD11b dur-
ing PMN activation by inflammatory stimuli, the 
adhesion molecule CD62L is rapidly cleaved in 
the cytoplasmic membrane of this cell type, a 
process necessary to stop the rolling of these 
cells in postcapillary venules [31] and the sub-
sequent firm adhesion to the endothelium [32]. 
From these sets of experiments, we can pro-
pose that the effects of hrGal-1 produce a break 
in the balance between adhesion molecule ex-
pression on PMNs, significantly diminishing 
CD11b and CD62L, with a consequent interfer-
ence in the cellular transmigration at 4 h in this 
experimental model of zymosan peritonitis. In 
contrast, at 24h high significant levels of CD11b 
expression was detected by flow citometry 
analysis on blood PMN from pretreated animals, 
but this effect was not associated with an in-
crease in cell transmigration on mesentery. 
Studies should be conducted to further eluci-
date the correlation between exogenous Gal-1 
and CD11b expression at later phases of inflam-
matory process. 
  
In conclusion, we have revealed an exogenous 
anti-inflammatory effect of Gal-1, associated 
with the modulation of innate immune cells and 
cytokine release involved in the acute inflamma-
tion response. In the initial phase of inflamma-
tion, Gal-1 was effective in regulating pro-
inflammatory IL-1β and TNF-α release and PMN 
migration to the mesentery through an imbal-
ance between CD11b and CD62L expression in 
these cells. In the late phase, the main effect of 
Gal-1 was an increase in the recruitment of peri-
toneal mononuclear phagocytic cells, important 
for process resolution. Thus, Gal-1 protein 
should be considered a potential target for the 
development of new therapeutic strategies for 
inflammatory diseases. 
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